NCT02874560View on ClinicalTrials.gov

Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia

CompletedOBSERVATIONAL

Enrollment

364

Participants

Timeline

Start Date

August 12, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

July 12, 2017

Conditions

Schizophrenia

Trial Locations (1)

Unknown

Paris

All Listed Sponsors

lead

Janssen-Cilag Ltd.

INDUSTRY

NCT02874560 - Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia | Biotech Hunter | Biotech Hunter